Fusion event
HBV-chr22 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGA| |GGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTT
End
21810167/21455878 (Hg38)
Nearest miRNA
hsa-mir-1286/Upstream/421606; hsa-let-7a-3/Downstream/197103;
Upstream sequence
CTCTCCCTGCAGTGCCAGGCTGCGTCCTTTCCCACGCAAAGGCTAGCCTCTGTGCTGTGGAGACCAGACGGGAGGCTGGAGGGCCTTGGTGGCAGTGTAA
Downstream sequence
GAGGCTGGGCCACCAGCAGGGCCCAGGTGTCTTTCTCAGTGCGCCTGGTGCTACCAAGAACCGTGCCCTGGGCAGATGGCTGAGGAGCGCTCACCTGTCC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.